The approval for MARGENZA was based on data from SOPHIA, a randomized Phase 3 clinical trial... Dec 17
Companies to commercialize margetuximab in the United States, if approved.... Dec 02
Export of test kit to entire Europe and numerous countries that recognize CE-IVD gains impetus ... Aug 05
-Advertisements-